Drug interactions
Brexucabtagene autoleucel + Thioguanine
Severity: Major
Brexucabtagene autoleucel and Thioguanine: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Thioguanine is a myelosuppressive antimetabolite and adds to the cytopenias and infection risk seen after CAR-T therapy. It may also impair CAR-T cell expansion and persistence.
What this interaction means in plain words
Brexucabtagene autoleucel and Thioguanine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Thioguanine belongs to Oncology.
Why it happens
Additive cytotoxic myelosuppression and immunosuppression, with possible impairment of CAR-T cell function.
What to do
Avoid thioguanine around CAR-T collection and infusion, and follow the product labeling on washout. If it must be used, monitor blood counts and give infection prophylaxis.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brexucabtagene autoleucel and Thioguanine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Thioguanine
Other interactions of Brexucabtagene autoleucel
Frequently asked questions
Can I take Brexucabtagene autoleucel with Thioguanine?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Thioguanine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Thioguanine is a myelosuppressive antimetabolite and adds to the cytopenias and infection risk seen after CAR-T therapy. It may also impair CAR-T cell expansion and persistence.
How serious is the interaction between Brexucabtagene autoleucel and Thioguanine?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid thioguanine around CAR-T collection and infusion, and follow the product labeling on washout. If it must be used, monitor blood counts and give infection prophylaxis.
What other medicines interact with Thioguanine?
MediHelp also lists interactions of Thioguanine with, for example, Adenovirus types 4 and 7 live, Axicabtagene ciloleucel, Belatacept. The full list is on the Thioguanine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
